Salo N Ooft
Overview
Explore the profile of Salo N Ooft including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
652
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oner D, Vernhes C, Balla-Jhagjhoorsingh S, Moureau A, Crabbe M, Salaun B, et al.
Front Immunol
. 2024 Nov;
15:1448578.
PMID: 39493753
Introduction: Respiratory syncytial virus (RSV) causes acute respiratory tract infection (ARTI) and reinfects adults throughout life, posing a risk for hospitalization in older adults (>60 years) with frailty and comorbidities....
2.
van de Haar J, Ma X, Ooft S, van der Helm P, Hoes L, Mainardi S, et al.
Nat Med
. 2023 Mar;
29(3):605-614.
PMID: 36864254
Genomics has greatly improved how patients with cancer are being treated; however, clinical-grade genomic biomarkers for chemotherapies are currently lacking. Using whole-genome analysis of 37 patients with metastatic colorectal cancer...
3.
Fernandes Neto J, Nadal E, Bosdriesz E, Ooft S, Farre L, McLean C, et al.
Nat Commun
. 2020 Jun;
11(1):3157.
PMID: 32572029
Resistance to targeted cancer drugs is thought to result from selective pressure exerted by a high drug dose. Partial inhibition of multiple components in the same oncogenic signalling pathway may...
4.
Ooft S, Weeber F, Dijkstra K, McLean C, Kaing S, van Werkhoven E, et al.
Sci Transl Med
. 2019 Oct;
11(513).
PMID: 31597751
There is a clear and unmet clinical need for biomarkers to predict responsiveness to chemotherapy for cancer. We developed an in vitro test based on patient-derived tumor organoids (PDOs) from...
5.
Weeber F, Ooft S, Dijkstra K, Voest E
Cell Chem Biol
. 2017 Aug;
24(9):1092-1100.
PMID: 28757181
Tumor organoids are 3D cultures of cancer cells that can be derived on an individual patient basis with a high success rate. This creates opportunities to build large biobanks with...